Stay updated with breaking news from Chen Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
今（15）日，2021集成电路产教融合高峰论坛在重庆举行，逾200名集成电路产业界、学术界的嘉宾探讨产学合作与人才培养。
After the hiatus caused by the pandemic rock groups are again taking to the stage in front of appreciative audiences Chinese indie rock band Miserable Faith gave an online concert on May 15, 2020. In itself, not that unusual. After all that is what rock bands do, right? Except this was their first show since the COVID-19 pandemic hit and the location was something special. It had been kept a secret until leading vocalist Gao Hu revealed it that night. "The Yangtze River is right behind us. We are performing in Wuhan," Gao said to about 400,000 people who watched the online concert. Wuhan, the...
Researcher Sentenced to 33 Months in Prison for Stealing Trade Secrets to Sell in China Posted on A hospital researcher on April 19 was sentenced to 33 months in prison for conspiring to steal trade secrets from an Ohio children’s hospital to sell in China, according to the Justice Department. Zhou Yu, 51, pleaded guilty in December 2020 to stealing at least five trade secrets relating to exosome research from the Nationwide Children’s Hospital’s Research Institute in Columbus, Ohio, where he had worked for 10 years until 2017. Exosomes are small sacs of fluid released from cells that ...
A Dialogue Between Graham Allison, and Wang Huiyao On April 6, the Center for China and Globalization (CCG) hosted a virtual dialogue between Professor Graham T. Allison, the founding dean of Harvard’s John F. Kennedy School of Government and author of Destined for War: Can America and China Escape Thucydides‘ Trap? and President of CCG, Dr. Wang Huiyao, joined by Professor Li Chen, director of Center for International Security and Strategy at School of International Studies, Remin University of China. Topics discussed included great power competition in historical perspective, new para...
Date Time Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma (From left) First and corresponding author Monika Metzger, M.D., Departments of Oncology and Global Pediatric Medicine; co- senior author Matthew Krasin, M.D., Department of Radiation Oncology; and co-senior author Melissa Hudson, M.D., Cancer Survivorship Division director. Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition of brentuximab vedotin achieve...